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Abstract
A wide variety of animal models in cardiomyopathy have been established for the
discovery  of  pathophysiological  mechanisms,  diagnosis,  and  treatment  of  human
myocardial disease. Experimentally, several species including rodents, rabbit, canine,
pig,  and sheep have  been  involved in  the  fundamental  research  in  medical  field.
However, knowledge about naturally occurring myocardial disease in animals is limited
in the veterinary medicine. Among small and large animals that develop myocardial
disease,  to the best  of  authors’  knowledge,  naturally occurring cardiomyopathy in
canine  and  feline  is  commonly  encountered  in  veterinary  clinical  setting.  Their
pathophysiology is not fully described; specific pathophysiology is documented in both
species,  which  resembles  those  of  humans.  These  conditions  are  hypertrophic
cardiomyopathy (HCM) in feline and dilated cardiomyopathy (DCM) in canine. Each
has distinct etiology and pathophysiology. In order to translate new findings from
naturally  occurring  cardiomyopathies  in  small  and  large  animals  into  medical
applications, knowledge gained through animals with cardiomyopathies becomes a
necessary approach. The purpose of this chapter is to introduce the overview of findings
on  small  and  large  animals  with  naturally  occurring  cardiomyopathies  already
investigated.
Keywords: animal model, canine dilated cardiomyopathy, feline hypertrophic cardio‐
myopathy, naturally occurring cardiomyopathies
1. Introduction
Several animal models in cardiomyopathy have been established for the discovery of patho‐
physiological mechanisms, diagnosis, and treatment of human myocardial disease. Experi‐
mentally, rodents, rabbit, canine, pig, sheep, and other species have been involved in the
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fundamental research in medical field [1–7]. Although anatomic and biochemical differences
between species are critical, each experimentally induced animal model plays an important role
for translation to clinical practice in human. In addition to experimentally induced animal
models, naturally occurring cardiomyopathies in small and large animals offer an excellent
opportunity to evaluate novel therapies for those of human. However,  knowledge about
naturally occurring myocardial disease in animals is limited in the veterinary medicine. Among
animals that develop myocardial disease, to the best of authors’ knowledge, cardiomyopathy
in canine and feline is  commonly encountered in veterinary clinical  setting [8–12].  Their
pathophysiology is not always clearly described yet; however, specific features are documented
in both canine and feline. Briefly, naturally occurring myocardial disease is one of the most
common heart diseases in canine and feline. A number of remarkable similarities have been
reported between these animals and humans [13,  14].  Several causes concerning genetic,
metabolic, inflammatory, nutritional, infectious, and drug‐induced myocardial disease have
been reported as canine and feline idiopathic or secondary myocardial disease [15, 16]. Generally
speaking, treatment strategy of these naturally occurring diseases in veterinary clinical setting
is based on those of humans. Therefore, this chapter provides pathophysiological aspects of
these diseases.
Dilated cardiomyopathy (DCM) was first reported in 1970, as congestive heart failure (CHF).
It is characterized by chamber dilation and myocardial systolic and diastolic dysfunction.
DCM appears to be common in canine, which has been suspected to be inherited defects
and mainly affects the certain large‐ to giant‐sized pure‐bred such as English Cocker
Spaniels, Doberman Pinschers, Irish Wolfhounds, Newfoundlands, Boxers, German Short‐
haired Pointers, Portuguese Water Dog, Airedale Terriers, St. Bernards, Standard Poodles,
Scottish Deerhounds, Afghan Hounds, and other breeds [8, 15–17]. Myocardial dysfunction
results from ischemia, tachycardia, and trauma in canine myocardial disease. An underlying
disease associated with neoplasia, renal disease, immune‐mediated hemolytic anemia, acute
pancreatitis, disseminated intravascular coagulopathy (DIC), myocardial infarction, mitral
insufficiency, and other disease results in ischemic myocardial disease. Atrioventricular
nodal‐reciprocating tachycardias can lead to the tachycardia‐induced cardiomyopathy in
several breeds. However, hypertrophic cardiomyopathy (HCM) occurs less often in canine
[15–17].
On the other hand, HCM is being the most commonly diagnosed cardiomyopathy in feline [10,
18, 19]. It is prevalent in certain populations. The disease is known to be inherited in some
breeds, most notably The Domestic Shorthair, Turkish Van, Maine Coon, Persian, Ragdoll,
Sphynx, Scottish Fold Cats, Chartreux, British Shorthair, Norwegian Forest Cat, Persian, and
other breeds [14–16, 18]. The pathogenic mechanisms responsible for the development of HCM
remain unclear; however, causal genetic mutations in genes encoding the sarcomere protein
myosin‐binding protein C (MYBPC3) have been identified in specific breeds such as Maine
Coons and Ragdolls [14, 19–21].
Limited information exists on naturally occurring cardiomyopathies in large animals such
as swine, cattle, and other species. Generally, these large animals are classified as farm
animals and treated under group control. Compared with small animal veterinary practice,
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which mainly treats canine and feline, large animals are not potentially therapeutic objec‐
tives. From this circumstance, few opportunities exist for veterinarian to treat the disease.
Even though numerous anatomic and biochemical differences exist, naturally occurring
disease in large animal species can provide significant advantages for understanding those
human conditions.
2. Canine DCM
2.1. Etiology and pathogenesis
The canine DCM can be divided into two categories: idiopathic and secondary (Table 1).
The exact underlying molecular and biochemical mechanisms for canine DCM are generally
not established in all cases. However, the etiology concerning genetic, nutritional, infectious,
metabolic, inflammatory, drug‐ or toxin‐induced myocardial hypokinesis have been
proposed in canine DCM [17]. In idiopathic cases, genetic basis is thought to exist especially
in certain breeds with high prevalence or familial occurrence of disease [15–17]. Large and
giant breeds such as Great Danes, Scottish Deerhounds, Boxers, St. Bernards, Newfound‐
lands, Dalmatians, Doberman Pinschers, Irish Wolfhounds, and other breeds have been
documented [8, 15, 16]. Newfoundlands, Irish Wolfhounds, Boxers, and Doberman Pinschers
appear to have an autosomal dominant mode of transmission pattern of inheritance [8, 22,
23]. An autosomal recessive transmission has been documented in the inherited form of
DCM in juvenile Portuguese Water Dogs [24, 25]. The disease is rapidly progressive and
fatal in puppies. In some German Short‐haired Pointer littermates, DCM appears to be an
X‐linked disorder caused by mutations in the Duchenne muscular dystrophy (DMD) gene
[8, 26]. This gene codes for dystrophin, which is thought to strengthen muscle fiber
membranes.
Myocardial function can impair result from a variety of causes including infections, inflam‐
mation, nutritional deficiencies, metabolic abnormalities, certain drugs, and other factors.
These factors can lead to canine secondary myocardial disease. The antineoplastic drug
doxorubicin and ethyl alcohol can cause severe myocardial damage and death. Plant toxins
(e.g., Taxus, foxglove, black locust, buttercup, gossypol), cocaine, cobalt, catecholamines, and
anesthetic drug can also affect the myocardial function [8, 15–17]. Carnitine and taurine
deficiencies have been described in canine DCM [8]. L‐Carnitine deficiency is not a primary
cause of canine DCM; however, in Boxers, Doberman Pinschers, American Cocker Spaniels,
Irish Wolfhounds, Newfoundlands, and Great Danes, low myocardial L‐carnitine concentra‐
tion has been reported [15]. L‐Carnitine is an essential component of the long‐chain fatty acids,
which is an important energy‐producing substrate of the myocardium. Taurine is known to
regulate calcium influx across membranes in heart muscle. However, most cases with canine
DCM are not taurine deficient; a reversible canine DCM associated with low plasma taurine
concentration was reported in Cocker Spaniels [27]. Low plasma taurine level has also been
described in Golden Retrievers, Labrador Retrievers, St. Bernards, Dalmatians, and other
breeds with DCM.
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Etiology/pathogenesis Breed References
Idiopathic DCM
Genetic disorder
Dystrophin German Short‐haired Pointers Schatzberg et al. [47]
Desmin Doberman Pinschers Stabej et al. [48]
Titin‐cup Irish Wolfhounds Philipp et al. [49]
α‐actinin Doberman Pinschers O’Sullivan et al. [50]
Striatin Boxers Cattanach et al. [51]
Secondary DCM
Nutritional disorder
L‐Carnitine Doberman Pinschers, Boxers Keene et al. [52]
American Cocker Spaniels Kittleson et al. [53]
Metabolic disorder
Thyroid hormone Great Dane Phillips and Harkin [54]
Alaskan Malamute Flood and Hoover [55]
Doberman Pinschers Beier et al. [56]
Immunological disorder
Anti‐mitochondrial antibodies English Cocker Spaniel Day [57]
Canine adenovirus type 1 Crossed breed Maxson et al. [58]
Table 1. Possible factors of naturally occurring canine DCM.
2.2. Pathophysiology
Dilation of all cardiac chambers is typical in canine DCM [8, 15, 16, 28]. Decreased ventricular
contractility is the major functional defect. Compensatory mechanisms become activated as
progressive cardiac chamber dilation and remodeling develop as cardiac output worsens.
Development of higher end‐diastolic pressure, venous congestion, and congestive heart failure
occurs in response to increased diastolic stiffness. Valve insufficiency also occurs because of
cardiac enlargement and papillary muscle dysfunction. Arterial fibrillation (AF) is typical in
canine DCM [15].
2.3. Histologic description
Gross anatomically, canine idiopathic DCM reveals marked dilation of all four cardiac
chambers and/or predominantly dilation of the left chambers [8, 29–31]. Generally, myocardial
hypertrophy is evident in the lesion. Distinct two histological forms of canine DCM have been
reported: the fatty infiltration‐degenerative type observed in specific breeds such as Boxers
and Doberman Pinschers, and the attenuated wavy fiber type reported in medium‐, large‐,
and giant‐sized breed (Table 2). Histological forms such as vacuolar degeneration of myofib‐
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ers, atrophic myofibers, lipid deposits, and fatty infiltration replacing myofibers are evident
for the fatty infiltration‐degenerative type. On the other hand, the attenuated wavy fiber type
seems to be a major histological form of canine DCM. The myofibers are stretched and thinner
than normal with wavy appearance. The morphological alterations including myofiber
atrophy, impairing wavy appearance to the fibers, and diffuse infiltration of subendocardial
fibrosis were reported [8]. These lesions were most abundant in the lateral wall of the left
ventricle (LV) [32, 33].
References Breed
Fatty infiltration-degenerative type
Calvert et al. [59] Doberman Pinschers
Harpster et al. [34] Boxers
Hazlet et al. [60] Doberman Pinschers
Tidholm and Jünsson [61] Newfoundland
Calvert et al. [62] Doberman Pinschers
Dambach et al. [25] Portuguese Water Dogs
Everett et al. [63] Doberman Pinschers
Vollmar et al. [64] Doberman Pinschers
Lobo et al. [65] Estrela Mountain Dogs
Attenuated wavy fiber type
Tilley and Liu [66] Great Dane, Doberman Pinschers, Irish Wolfhound
Sandusky et al. [67] Afghan Hound, Doberman Pinschers, Great Dane
Tidholm et al. [33] Large‐ and medium‐size breeds
Dambach et al. [25] Portuguese Water Dogs
Tidholm et al. [32] Newfoundlands
Alroy et al. [68] Portuguese Water Dogs
Vollmar et al. [69] Doberman Pinschers
Sleeper et al. [24] Portuguese Water Dogs
Table 2. Two distinct histological forms of canine idiopathic DCM.
2.4. Survival and prognosis
Prognosis in canine DCM varies from weeks to several years. Sudden death may occur before
the development of disease. Survival rate of Doberman Pinschers with fatty infiltration‐
degenerative type of DCM is shorter than attenuated wavy fiber type of those with DCM [8].
3. Cardiomyopathy in Boxers
Inherited cardiomyopathy in Boxers has similar features to arrhythmogenic right ventricular
cardiomyopathy (ARVC) [15, 23]. Three forms were originally described by Harpster in 1983
Cardiomyopathies in Animals
http://dx.doi.org/10.5772/65060
335
including the cases with asymptomatic arrhythmias, ventricular tachyarrhythmias, cardiac
arrhythmias, and congestive heart failure [34]. The disease appears to have an autosomal
dominant inherited pattern. The Boxers with cardiac arrhythmias and congestive heart failure
is considered to be a form of canine DCM, which is characterized by left and right ventricular
myocardial systolic dysfunction [15, 23]. Histologic form of the disease includes myofibers
atrophy, fibrosis, and fatty infiltration in the right ventricular wall. Deletion in the desmosomal
striatin gene is associated with the disease developed in Boxer with ARVC [23]. The prognosis
is varied in the forms of disease but survival is less than 6 months in case of CHF. Sudden death
is common in asymptomatic cases.
4. Feline HCM
4.1. Etiology and pathogenesis
Recent report suggested that feline cardiomyopathy may be classified as HCM, hypertrophic
obstructive cardiomyopathy (HOCM), restrictive cardiomyopathy (RCM), dilated cardiomy‐
opathy, arrhythmogenic right ventricular cardiomyopathy, and unclassified cardiomyopathy
(UCM) based on echocardiography and other factors [12]. However, diagnosis is quite
challenging because of complexity of the disease. Feline idiopathic HCM is the most commonly
diagnosed heterogeneous disease, which is transmitted in autosomal dominant trait in some
specific breeds [15]. The disease is more frequent in male than in female. Genetic mutations in
gene encoding in sarcomere protein myosin‐binding protein C (MYBPC3) is associated with
the development of disease in Manine Coon Cats (A31P mutation) and Ragdoll Cats (R820W
mutation) [18]. Other breeds including Domestic Short Hair, Norwegian Forest Cats, Sphinx,
Bengals, Chartreux, British Shorthairs, European, Scottish Folds, Cornish Rex, and Persian
breeds are also high in disease prevalence but causative mutations associated with disease
have yet to be documented [11, 15, 16]. In addition to specific gene mutation, feline myocardial
hypertrophy results from possible causes such as an excessive production of catecholamines,
myocardial ischemia, fibrosis, primary collagen abnormality, and abnormalities in myocardial
calcium‐handling process [15].
4.2. Pathophysiology
The disease is characterized by papillary muscle and LV hypertrophy, systolic anterior motion
(SAM) of the mitral valve, diastolic dysfunction, end‐systolic cavity obliteration, and enlarge‐
ment of the left atrium [14, 35]. Abnormal sarcomere function results from myocyte hypertro‐
phy and increased collagen synthesis. Asymmetric or symmetric LV free‐wall concentric
hypertrophy with interventricular septum is the characteristic form of the disease [36]. Some
have limited abnormality in the basal septum and/or papillary muscles. These different
patterns of hypertrophy may be caused by different phenotypic expression between different
breeds.
Myocardial hypertrophy and reduced ventricular distensibility result in increased diastolic
pressure and LV filling accompanying increased left arterial (LA) and pulmonary venous
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pressure. Secondary right‐sided congenital heart failure (CHF) may occur in response to
prolonged pulmonary vasoconstriction and increased pulmonary arterial pressure. LV outflow
obstruction accompanying ejection murmur results from LV papillary muscle hypertrophy.
Several factors contribute to myocardial ischemia, which leads to fibrosis, arrhythmias, and
other complications. CHF, arterial thromboembolism (ATE), and sudden cardiac death are
common clinical manifestation in end‐stage feline HCM [15].
4.3. Histologic description
Gross anatomy is characterized by moderate to severe papillary muscle and LV concentric
hypertrophy (Figure 1). Histologic findings based on hematoxylin and eosin (HE) staining and
other specific markers revealed several abnormalities including multifocal myocardial
interstitial fibrosis, myofiber disarray, diffuse myocyte hypertrophy with or without scattered
individual cell necrosis, and arteriosclerosis in papillary muscles in the LV wall, interventric‐
ular septum, and intramural coronary artery [10, 37]. Recent evidence showed remodeling of
the myofibrils and interfibrillar mitochondria, sarcolemmal remodeling with depletion of the
subsarcolemmal mitochondria, changes of Z‐disc morphology, myofibrillar degeneration, and
endomysial fibrosis based on electron microscopic examination [10].
Figure 1. Gross morphologic features of heart from feline with HCM. (A) Overview of the heart from feline HCM. (B)
Hypertrophy of ventricular septum (VS) in relation to left ventricular (LV) free wall. RV = right ventricle. Images cour‐
tesy of Prof. Kinji Shirota.
4.4. Survival and prognosis
Some prognostic factors such as heart rate and LA size are associated with survival time [12].
The prognosis is worse in case with ATE and/or CHF. Restrictive cardiomyopathy may be a
consequence of the end stage of myocardial failure and infarction caused by HCM. Several
factors cause a secondary RCM including tumor and infectious disease that were documented
[15]. The prognosis is poor for feline with RCM accompanied by heart failure.
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5. Other species
5.1. Swine
Experimentally induced porcine model of cardiomyopathy is widely used for medical
applications [2, 38]. On the other hand, we have limited knowledge about naturally occurring
swine cardiomyopathies. To date, naturally occurring porcine HCM and DCM have been
described [39–41]. In addition to experimentally induced animal models, characteristics of
naturally occurring affected pigs would be useful for translational research.
Several findings from swine HCM resemble those of humans with HCM. Higher incidence of
specific breeds such as Landrace, Yorkshire, and Duroc were reported [39]. Pathological
findings including increased number of mitochondria contained in the LV, increased amount
of collagen matrix and abnormality in intramural coronary arteries, alternation of endogenous
antioxidant enzymes, and decreased Ca2+‐ATPase activity in the LV are identical to those found
in humans [39]. Histological abnormalities in swine HCM including abnormal intramural
coronary arteries, subendocardial fibrosis in the ventricular septum, myocardial fibrosis,
abnormalities in matrix connective tissue in myocardium, increased perimysial coil, and weave
fibers of matrix connective tissue space between myocytes were documented [41, 42].
Recently, the case of spontaneous DCM was recognized in Yorkshire‐Landrace crossbred [40].
The postmortem investigation after sudden death of this case revealed marked dilated
ventricles and thinned ventricular walls and interventricular septum. Characteristics of gross
anatomy and histological findings including multifocal myofiber attenuation and loss of
myofiber cross striations supported the diagnosis of swine DCM. Cardiac lesions observed in
the reported case were consistent with DCM as recognized in other species.
5.2. Cattle
Few reports on cardiomyopathies in cattle were descried [43, 44]. Hereditary cardiomyopathy
in cattle has been described in some breeds including Japanese Black Calves, Holstein‐Friesian‐
Cattle, Simmental/Red and White Holstein crossbreds, and Polled Hereford Calves [44, 45].
Recently, evidence suggested that specific breeds appear to have an autosomal dominant mode
of transmission pattern of inheritance [45]. However, limited information exists about patho‐
physiological features compared with those of canine and feline. Affected cattle had multifocal
myocardial degeneration and necrosis under histological investigation [46].
6. Conclusion
Naturally occurring inherited canine DCM and feline HCM are well‐recognized myocardial
disease in veterinary clinical setting. Although anatomic and biochemical differences between
species are critical, reported findings resemble those of human disease condition. Little is
known about naturally occurring cardiomyopathies in large animals but evidence suggested
that they also develop spontaneous myocardial disease, which resembles those of other species
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including human. Given the similarities of cardiomyopathies in both human and other species,
the knowledge of naturally occurring myocardial disease in small and large animals may help
expand the understanding of disease pathophysiology.
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